[{"indications": "Indications\u00a0see under Dose", "name": "NEOSTIGMINE METILSULFATE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "15 Anaesthesia", "15.1 General anaesthesia", "15.1.6 Drugs for reversal of neuromuscular blockade", "Anticholinesterases", "NEOSTIGMINE METILSULFATE"], "cautions": "Cautions\u00a0section 10.2.1 and notes above; glycopyrronium or\r\natropine should also be given", "side-effects": "Side-effects\u00a0section 10.2.1 and notes above", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/6670.htm", "doses": ["Reversal of non-depolarising neuromuscular blockade, by intravenous injection over 1 minute, adult over 18 years, 2.5\u00a0mg repeated if necessary (max. 5\u00a0mg) after or\r\nwith glycopyrronium or atropine; child under 18 years see BNF for Children", "Myasthenia gravis, see section 10.2.1"], "pregnancy": "Pregnancy\u00a0section 10.2.1"}]